The TE Air is reportedly the first handheld ultrasound device to offer dual connectivity to mobile devices or touch-based ultrasound systems.
Offering the promise of enhanced connectivity and dedicated presets for a variety of clinical exams, Mindray has launched TE Air, a wireless handheld ultrasound modality.
Mindray said the TE Air offers enhanced utility and accessibility, claiming that the device is the first handheld ultrasound that can be connected to mobile devices or the touch-based TE X Ultrasound System.
“The TE Air is a leap forward in ultrasound technology, offering comprehensive functionality inside or outside the hospital environment,” noted Wayne Quinn, the president of Mindray North America. “The new 2-in-1 innovative solution empowers clinicians to overcome the traditional constraints of cords and confined spaces, giving them access to premium scanning capability when and where they need it.”
The company noted a number of additional features with TE Air including:
• a phased array with exam presets for a variety of clinical exams including cardiac exams, transcranial imaging, lung imaging and OB/GYN exams;
• single crystal technology that facilitates high-resolution imaging quality; and
• a waterproof design that allows for easy cleaning of the device with compatible disinfectant products.
New AI-Enabled Portable Ultrasound May Facilitate 50 Percent Reduction in Cardiac Imaging Scan Time
March 28th 2025Artificial intelligence (AI)-powered measurement capabilities provide key features with the Compact Ultrasound 5500CV device, which will be unveiled at the American College of Cardiology (ACC) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.